Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease Evidence Review and Practical Considerations

被引:10
|
作者
Copeland, Carla R. [1 ]
Collins, Bridget F. [2 ]
Salisbury, Margaret L. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37235 USA
[2] Univ Washington, Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
environmental lung disease; hypersensitivity pneumonitis; pulmonary fibrosis; IDIOPATHIC PULMONARY-FIBROSIS; OCCUPATIONAL HYPERSENSITIVITY PNEUMONITIS; ASTHMA MORBIDITY; FARMERS LUNG; RISK-FACTORS; CIGARETTE-SMOKING; PROTECTIVE VALUE; MULTI-TRIGGER; ANTIGEN; METAL;
D O I
10.1016/j.chest.2021.02.021
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A relationship between inhalational exposure to materials in the environment and development of interstitial lung disease (ILD) is long recognized. Hypersensitivity pneumonitis is an environmentally -induced diffuse parenchymal lung disease. In addition to hypersensitivity pneumonitis, domestic and occupational exposures have been shown to influence onset and progression of other ILDs, including idiopathic interstitial pneumonias such as idiopathic pulmonary fibrosis. A key component of the clinical evaluation of patients presenting with ILD includes elucidation of a complete exposure history, which may influence diagnostic classification of the ILD as well as its management. Currently, there is no standardized approach to environmental evaluation or remediation of potentially harmful exposures in home or workplace environments for patients with ILD. This review discusses evidence for environmental contributions to ILD pathogenesis and draws on asthma and occupational medicine literature to frame the potential utility of a professional evaluation for environmental factors contributing to the development and progression of ILD. Although several reports suggest benefits of environmental assessment for those with asthma or certain occupational exposures, lack of information about benefits in broader populations may limit application. Determining the feasibility, long-term outcomes, and cost-effectiveness of environmental evaluation and remediation in acute and chronic ILDs should be a focus of future research.
引用
收藏
页码:219 / 230
页数:12
相关论文
共 50 条
  • [41] Managing Fatigue in Patients With Interstitial Lung Disease
    Kahlmann, Vivienne
    Moor, Catharina C.
    Wijsenbeek, Marlies S.
    CHEST, 2020, 158 (05) : 2026 - 2033
  • [42] Quantitative assessment of lung stiffness in patients with interstitial lung disease using MR elastography
    Marinelli, John P.
    Levin, David L.
    Vassallo, Robert
    Carter, Rickey E.
    Hubmayr, Rolf D.
    Ehman, Richard L.
    McGee, Kiaran P.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2017, 46 (02) : 365 - 374
  • [43] Diagnostic assessment of patients with interstitial lung disease
    Gulati, Mridu
    PRIMARY CARE RESPIRATORY JOURNAL, 2011, 20 (02): : 120 - 127
  • [44] The environmental epidemiology of idiopathic interstitial lung disease including sarcoidosis
    Mapel, DW
    Coultas, DB
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 20 (06) : 521 - 529
  • [45] The evaluation of 92 interstitial lung disease patients
    Sengul, Bilal
    Uzun, Oguz
    Findik, Serhat
    Atici, Atilla Guven
    Erkan, Levent
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2009, 57 (03): : 314 - 326
  • [46] Diagnostic Yield and Complications of Transbronchial Lung Cryobiopsy for Interstitial Lung Disease A Systematic Review and Metaanalysis
    Johannson, Kerri A.
    Marcoux, Veronica S.
    Ronksley, Paul E.
    Ryerson, Christopher J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (10) : 1828 - 1838
  • [47] Management of interstitial lung disease in elderly patients
    Meyer, Keith C.
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 483 - 492
  • [48] A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
    Ryerson, Christopher J.
    Corte, Tamera J.
    Myers, Jeffrey L.
    Walsh, Simon L. F.
    Guler, Sabina A.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (06)
  • [49] Chemotherapy for patients with advanced lung cancer with interstitial, lung disease: a prospective observational study
    Koda, Keigo
    Enomoto, Yasunori
    Aoshima, Yoichiro
    Amano, Yusuke
    Kato, Shinpei
    Hasegawa, Hirotsugu
    Matsui, Takashi
    Yokomura, Koshi
    Mochizuki, Eisuke
    Matsuura, Shun
    Koshimizu, Naoki
    Morita, Meiko
    Kojima, Suguru
    Watanabe, Ayano
    Oyama, Yoshiyuki
    Ikeda, Masaki
    Kusagaya, Hideki
    Uto, Tomohiro
    Sato, Jun
    Imokawa, Shiro
    Kono, Masato
    Hashimoto, Dai
    Kamiya, Yosuke
    Toyoshima, Mikio
    Asada, Kazuhiro
    Morita, Masako
    Mikamo, Masashi
    Yasui, Hideki
    Hozumi, Hironao
    Karayama, Masato
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Inui, Naoki
    Suda, Takafumi
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [50] Rheumatological evaluation of patients with interstitial lung disease
    Ottaviani, S.
    Khaleche, S.
    Borie, R.
    Debray, M-P
    Dieude, P.
    Crestani, B.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (01) : 34 - 41